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and while liver transplantation can be life saving, it is 
imperative to perform a thorough evaluation to screen 
for potential contraindications[1]. We describe an unusual 
case of  a patient who developed ALF due to natural killer 
(NK)-like T-cell leukemia/lymphoma, a diagnosis with 
important implications, as it is a contraindication to liver 
transplantation. While a review of  the literature shows that 
previously published case series have found this rare sub-
type of  T-cell malignancy to involve the liver, we believe 
that this is the first report of  it presenting as ALF. 
CASE REPORT
A previously healthy 63 year-old man was admitted for 
three mo of  fatigue, one mo of  increasing abdominal 
girth and peripheral edema, two weeks of  jaundice, and 
one week of  confusion. He noted recent fevers, anorexia, 
weight loss, and day-night reversal. He had never received 
a blood transfusion or used intravenous or intranasal 
drugs. He had no tattoos or recent travel. He did not take 
prescription or over-the-counter medications, or nutritional 
or herbal supplements. He admitted using alcohol heavily 
in the past, but had been sober for more than 10 years. His 
family corroborated this information. There was no family 
history of  liver disease.
On physical examination he was jaundiced and had 
findings consistent with hepatic encephalopathy including 
slurred speech and asterixis. He had moderate ascites, 
peripheral edema, and scattered spider angiomata. The 
liver was normal in size, but splenomegaly was detected.
Routine laboratory tests revealed hyponatremia, 
hypoalbuminemia, hyperbilirubinemia, thrombocytopenia, 
and prolonged prothrombin time not due to vitamin K 
deficiency (Table 1). The white blood cell count was 5.1 
× 109/L with atypical lymphocytes comprising 53% of  
the differential (Figure 1). Other diagnostic testing found 
a negative toxicology screen, 90% iron saturation, negative 
serologies for hepatis A virus, hepatitis B virus, hepatitis C 
virus, human immunodeficiency virus, and human T-cell 
lymphotrophic virus (HTLV) types I and II. Serologies 
were also negative for anti-nuclear antibodies, anti-smooth 
muscle antibodies, and anti-mitochondrial antibodies. 
Serum protein electrophoresis, alpha-1 anti-trypsin levels, 
ceruloplasmin levels, and alpha-fetoprotein were normal. 
Serum ammonia level was not measured. Abdominal 
ultrasound showed a normal liver size with heterogeneous 
echotexture, splenomegaly, and patent vasculature. Head 
CT scan excluded mass lesions and infiltrating disease.
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Abstract
Acute liver failure (ALF) is a medical emergency requiring 
immediate evaluation for liver transplantation. We 
describe an unusual case of a patient who presented 
with ascites, jaundice, and encephalopathy and was 
found to have ALF due to natural killer (NK)-like T cell 
leukemia/lymphoma. The key immunophenotype was 
CD2+, CD3+, CD7+, CD56+. This diagnosis, which 
was based on findings in the peripheral blood and 
ascitic fluid, was confirmed with liver biopsy, and was a 
contraindication to liver transplantation. A review of the 
literature shows that hematologic malignancies are an 
uncommon cause of fulminant hepatic failure, and that 
NK-like T-cell leukemia/lymphoma is a relatively recently 
recognized entity which is characteristically CD3+ and 
CD56+. This case demonstrates that liver biopsy is 
essential in diagnosing unusual causes of acute liver 
failure, and that infiltration of the liver with NK-like T-cell 
lymphoma/leukemia can cause acute liver failure. 
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INTRODUCTION
Acute l iver fai lure (ALF) is a medical emergency, 
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Diagnostic paracentesis at a site in the left-lower-
quadrant demonstrated a serum albumin-ascites gradient 
of  12 g/L, 12 475 red blood cells (RBCs)/mm3 and 1875 
white blood cells (WBCs)/mm3 with a differential of  
1% neutrophils, 4% monocytes and 95% lymphocytes. 
Because the lymphocytes were described as atypical with 
mitotic figures, a repeat paracentesis was performed at 
a right-lower-quadrant site. This revealed 1550 RBCs/
mm3 and 250 WBCs/mm3 with the same differential 
and atypical cells. A sample of  the ascitic f luid was 
sent for cytology (Figure 2). The peripheral blood flow 
cytometric immunophenotypes were as follows: CD2+, 
CD3+, CD7+, CD56+, CD4-, CD5-, CD8-, CD57-, 
and CD16-. A bone marrow biopsy revealed the same 
findings. Cytogenetic analysis of  the bone marrow aspirate 
revealed the following karyotypes: 43, X, -Y, add (4) (q35), 
-5, dic (6;19) (q?23; q13.4), -10, -11, -13, -14, -16, -18, 
add(22)(p11), +6 mars.
S ince the pa t i en t ’s coagu lopa thy p roh ib i t ed 
percutaneous liver biopsy, transjugular liver biopsy was 
performed for definitive diagnosis. There was no evidence 
of  cirrhosis, but there was diffuse hepatic infiltration by 
a malignant lymphoid population (Figures 3A and 3B) 
which was immunohistochemically stained as follows: 
CD3+, CD20-, Epstein-Barr virus (EBV)-, granzyme B+, 
T1A-1+, and TdT-. The paraffin block of  the liver biopsy 
was analyzed for a T-cell receptor (TCR) gamma gene 
rearrangement by polymerase chain reaction, and there was 
no evidence of  a clonal TCR gamma gene rearrangement. 
The patient was diagnosed with NK-like T-cell 
lymphoma/leukemia as the cause of  liver failure on 
hospital d 4. This was deemed a contraindication to 
transplantation. His course was complicated on d 3 by 
bleeding duodenal ulcers amenable to standard endoscopic 
treatment. On d 4-6, high-dose methylprednisolone failed 
to induce remission, and his hepatic synthetic function and 
mental status worsened. On d 10 and 11, a salvage regimen 
of  gemcitabine was unsuccessful in inducing remission. 
On d 12, neutropenia, fever, and hypotension developed, 
and the patient’s jaundice and encephalopathy progressed. 
The patient expired on hospital d 12.
DISCUSSION
The diagnosis of  acute liver failure is a medical emergency 
because mortality is high without liver transplantation[1]. 
However, thorough evaluation is mandatory to exclude 
contraindications to l iver transplantation such as 
Table 1 Laboratory results
Test Result (normal range)
Sodium 128 mmol/L (135-145)
Creatinine 1.1 mg/dL (0.8-1.4)
AST (SGOT) 85 U/L (19-55)
ALT (SGPT) 40 U/L (19-72)
Total bilirubin 8.4 mg/dL (0.0-1.2)
Direct bilirubin 7.1 mg/dL (0.0-0.4)
Alkaline phosphatase 138 U/L (38-126)
GGT 80 U/L (13-68)
Serum albumin 1.7 g/dL (3.5-5.0)
Ascitic fluid albumin 0.5 g/dL (unspec)
White blood cell count 5.1 × 109/L (4.5-11)
      neutrophils (%) 47
      monocytes (%) 0
      lymphocytes (%) 53 with atypical forms present
      eosinophils (%) 0
Hematocrit (%) 33.3 (41-53)
Platelet count 31 × 109/L (150-440)
Prothrombin time 20 s (11-14)
International normalized ratio (INR) 1.7
Figure 1  Peripheral blood smear-high power (1000 ×) view of atypically large 
lymphoid cells with blastic chromatin and abundant cytoplasm containing fine 
azurophilic granules.
Figure 2  Ascites cell-block- high power (600 ×) view of large lymphocytes 
with molding, convoluted nuclear membranes, dense chromatin, and abundant 
cytoplasm.   Features are supportive of possible T-cell morphology.
Figure 3  Liver biopsy-low power (200 ×) view of the liver parenchyma infiltrated 
by a malignant lymphoid population composed of intermediate-sized to large 
atypical lymphocytes (A) and liver biopsy-high power (1000 ×) view of the liver 
parenchyma showing intermediate-sized to large atypical lymphocytes with very 
irregular nuclear contours and dense nuclear chromatin (B).
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Hematologic malignancies often incidentally involve the 
liver, but they uncommonly present as acute liver failure[3,4]. 
When they do so, however, they carry a poor prognosis[5]. 
Acute leukemias, Hodgkin’s disease, non-Hodgkin’s 
lymphoma, and transformation of  chronic leukemias have 
all been noted in case reports or case series to present as 
hepatic failure[5-20]. Infiltration of  the liver and subsequent 
hepatic dysfunction specifically by T-cell leukemias and 
lymphomas are more unusual, though it has been reported 
in both the pediatric[21,22] and adult patients[23-29].
Natural killer cells, typically identified morphologically 
as large granular lymphocytes, are recognized for their 
role in cell-mediated immunity[30]. They have characteristic 
immunophenotypes (CD3-, CD56+) which distinguish 
them from T cells (CD3+, CD56-). Other markers such 
as CD8 and the additional so-called NK-cell antigens 
(CD16 and CD57) are variably present[31-32]. Over the past 
two decades, it has been noted that NK cells undergo 
clonal expansion and malignant transformation[33]. This 
is believed to be a rare event, accounting for only a small 
fraction of  all T-cell malignancies, which themselves are 
thought to comprise approximately just 15% of  all non-
Hodgkin’s lymphoma[31,34]. NK-cell leukemia/lymphomas 
are categorized as either immature (and more aggressive) 
or mature (with an indolent course), and more commonly 
affect the nasopharynx and sinuses though they have 
also been reported to involve the skin, mucosa of  the 
gastrointestinal (GI) tract, testes, kidneys, and orbit[31,35]. 
They are seen more frequently in Asia, Mexico, and South 
America, ostensibly due to associations with EBV and 
HTLV[36-38]. Of  note, while they are commonly associated 
with hepatosplenomegaly they have not been reported to 
present with acute liver failure [31,39-41].
In contrast to NK cells, NK-like T-cells expressing 
features of  both T cells and NK cells, are defined by a 
CD3+, CD56+ immunophenotypes, and tend not to be 
associated with EBV[31]. The first reports of  NK-like T-cell 
leukemias and lymphomas[42,43] have described presentations 
including typical “B” symptoms such as fever, chills, night 
sweats and weight loss, as well as lymphadenopathy and 
splenomegaly. Disease involves the spleen, blood, marrow, 
GI tract, lung, kidneys, and liver, but none of  the patients 
presented with frank liver dysfunction. In most instances, 
the disease is aggressive and rapidly fatal, regardless of  
treatment regimen. A large series identified 49 Chinese 
patients with extra-nasal CD56+ disease, 34 of  whom are 
also CD3+[38]. Of  the 5 patients with liver involvement, 
all had reactive hemophagocytic syndrome but none 
presented with hepatic failure. Of  the 29 patients with 
follow-up information available, 24 died in a median time 
of  3.5 mo. A recent phenotypic analysis of  408 Japanese 
cases of  peripheral T/NK cell lymphoma had not 
described any with liver failure[44].
In th i s paper we present the c l in ica l course , 
immunophenotype, and cytogenetics of  what we believe 
to be the first reported case of  a patient with acute liver 
failure due to NK-like T-cell leukemia/lymphoma. This 
has implications beyond the rarity of  this particular 
patient’s condition. Because this patient had a history of  
alcohol consumption, his liver disease might have been 
ascribed to alcoholic hepatitis from a relapse of  alcohol 
use. However this case illustrates the importance of  fully 
analyzing unexpected findings. The atypical lymphocytes 
seen on the peripheral smear and in the ascitic fluid cell 
count differential were not attributed to a reactive process. 
Rather, they led to the transjugular liver biopsy which is 
essential in making the diagnosis, and underscores the role 
of  and importance of  liver biopsy when the etiology of  
liver failure is unknown.
In conclusion, a hematologic malignancy infiltrating 
the liver, although rare, is a contraindication to liver 
transplantation. It is mandatory to exclude such processes 
in the correct clinical context. In our case, liver biopsy 
allowed prompt diagnosis and recognition of  NK-like 
T-cell leukemia/lymphoma as the cause of  acute liver 
failure.
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